Effects of Statins on the Pharmacokinetics for Midazolam in Healthy Volunteers
NCT ID: NCT00716846
Last Updated: 2011-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2006-06-30
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study To Check The Analgesic And Anti-Inflammatory Effects Of Atorvastatin In Patients Undergoing Abdominal Surgery
NCT00902967
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
NCT00609063
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
NCT02590653
Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation
NCT00404716
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
NCT01761656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
statin-1
simvastatin
simvastatin
10mg, 2 weeks
statin-2
atorvastatin
atorvastatin
10mg
statin-3
pitavastatin
pitavastatin
2mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
simvastatin
10mg, 2 weeks
atorvastatin
10mg
pitavastatin
2mg
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamamatsu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Naoki Inui
Clinical Pharmacology and Therapeutics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hiroshi Watanabe, MD,PhD
Role: STUDY_CHAIR
Hamamatsu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamamatsu University School of Medicine
Hamamatsu, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hamamatsu 18-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.